Histopathological grade and response to chemotherapy in advanced soft tissue sarcomas-Reference-Cited by-同舟云学术

Histopathological grade and response to chemotherapy in advanced soft tissue sarcomas

Published:1993-01 Issue:6 Volume:29 Page:811-813
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Daugaard Søren,Glabbeke Martine v.,Schiødt Torben,Mouridsen Henning T.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Chemotherapy of advanced soft-tissue sarcomas;Antman;Sem Surg Oncol,1988

2. Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of Cancer;Bramwell;Sem Surg Oncol,1988

3. Cyclophosphamide, Vincristine, Adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas;Yap;Cancer Treat Rep,1980

4. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules;Pinedo;Cancer,1984

5. Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphantide-vincristine-adriamycin-dacarbazine (CYVADIC) combination;Bui;Cancer Chemother Pharmacol,1985

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients;Scientific Reports;2023-12-27

2. Establishment and validation of nomogram models for overall survival (OS) and cancer-specific survival (CSS) of patients with spindle cell sarcoma (SCS): A SEER database analysis.;2023-07-28

3. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma;International Journal of Hyperthermia;2015-12-15

4. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma;British Journal of Cancer;2014-12-23

5. The role of the EORTC pathologist in clinical trials;European Journal of Cancer;2002-03